KorrekturOpen Access · CC BY 4.0
Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression
Molecular Therapy · 2026-10 · 34 (10) · 6163
DOI: 10.1016/j.ymthe.2026.08.040 ↗Kurz gefasst
Korrektur in der Zeitschrift Molecular Therapy, 2026-10. Verfasst von Linda Zeng und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zeng, L., Shu, J., Zhong, S., Dong, X., Wu, Y., & Huang, X. (2026). Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression. Molecular Therapy, 34(10), 6163. https://doi.org/10.1016/j.ymthe.2026.08.040
Vancouver
Zeng L, Shu J, Zhong S, Dong X, Wu Y, Huang X. Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression. Molecular Therapy. 2026;34(10):6163. doi:10.1016/j.ymthe.2026.08.040
BibTeX
@article{Zeng2026,
author = {Zeng, Linda and Shu, Jingxian and Zhong, Shuping and Dong, Xin and Wu, Yongjian and Huang, Xi},
title = {Anti-CD19-engineered exosomes enable B cell-targeted anti-BAFF mRNA delivery to alleviate lupus progression},
journal = {Molecular Therapy},
year = {2026},
volume = {34},
number = {10},
pages = {6163},
doi = {10.1016/j.ymthe.2026.08.040}
}
EUVIMED